Abstract
Mutations in the WAF1/CIP1 gene were not found in 36 ovarian carcinomas, including tumours with loss of heterozygosity at the WAF1/CIP1 locus and/or lacking p53 mutations. In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1/CIP1 gene and ovarian carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wan, M., Cofer, K. & Dubeau, L. WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer. Br J Cancer 73, 1398–1400 (1996). https://doi.org/10.1038/bjc.1996.265
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.265
This article is cited by
-
Polymorphisms in the p53 pathway
Oncogene (2006)
-
Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25
Oncogene (1999)
-
Effects of enhancing p21 waf1 on proliferation and expression of G1cyclins andCDKs in human breast cancer cells
Chinese Science Bulletin (1999)